Colorectal cancer
RecruitingStudy on Using ctDNA to Guide Treatment in Patients with Metastatic Colorectal Cancer Using Oxaliplatin, Capecitabine, Calcium Folinate, Irinotecan, and Fluorouracil
Study on Using ctDNA to Guide Treatment in Patients with Metastatic Colorectal Cancer Using Oxaliplatin, Capecitabine, Calcium Folinate, Irinotecan, and Fluorouracil
- Disease:Colorectal cancer
- Substances:Calcium FolinateCapecitabine+6
Germany- Participants:18–64 years · 65+ years
- Substances:Calcium Folinate
- Sponsor:Aarhus University Hospital













